EA200500452A1 - METHODS OF TREATING ERECTILE DYSFUNCTION IN MEN - Google Patents

METHODS OF TREATING ERECTILE DYSFUNCTION IN MEN

Info

Publication number
EA200500452A1
EA200500452A1 EA200500452A EA200500452A EA200500452A1 EA 200500452 A1 EA200500452 A1 EA 200500452A1 EA 200500452 A EA200500452 A EA 200500452A EA 200500452 A EA200500452 A EA 200500452A EA 200500452 A1 EA200500452 A1 EA 200500452A1
Authority
EA
Eurasian Patent Office
Prior art keywords
erectile dysfunction
treating erectile
men
methods
patient
Prior art date
Application number
EA200500452A
Other languages
Russian (ru)
Inventor
Джеймс Л. Йиджер
Надир Бюйюктимкин
Сервет Бюйюктимкин
Original Assignee
Нексмед (Холдингс), Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by Нексмед (Холдингс), Инк. filed Critical Нексмед (Холдингс), Инк.
Publication of EA200500452A1 publication Critical patent/EA200500452A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

В изобретении представлены способы лечения эректильной дисфункции у пациента, страдающего от сопутствующего состояния, включающие внесение в ладьевидную ямку пациента индуцирующего эрекцию количества полутвердой композиции вазоактивного простагландина.Международная заявка была опубликована вместе с отчетом о международном поиске.The invention provides methods for treating erectile dysfunction in a patient suffering from a concomitant condition, including inserting into the patient's scaphoid fossa inducing an erection of the amount of the semi-solid composition of the vasoactive prostaglandin. The international application was published along with an international search report.

EA200500452A 2002-09-06 2003-09-05 METHODS OF TREATING ERECTILE DYSFUNCTION IN MEN EA200500452A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US48327803P 2003-06-27 2003-06-27
PCT/US2003/027885 WO2004022064A1 (en) 2002-09-06 2003-09-05 Methods of treatment of male erectile dysfunction

Publications (1)

Publication Number Publication Date
EA200500452A1 true EA200500452A1 (en) 2005-10-27

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500452A EA200500452A1 (en) 2002-09-06 2003-09-05 METHODS OF TREATING ERECTILE DYSFUNCTION IN MEN

Country Status (10)

Country Link
EP (1) EP1534297A1 (en)
JP (1) JP2006512291A (en)
KR (1) KR20050057245A (en)
CN (1) CN1674912A (en)
AU (1) AU2003273291A1 (en)
CA (1) CA2493723A1 (en)
EA (1) EA200500452A1 (en)
IL (1) IL166273A0 (en)
NO (1) NO20050658L (en)
WO (1) WO2004022064A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
WO2004084861A2 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Angiogenesis promotion by prostaglandin compositions and methods
EP1605948A1 (en) * 2003-03-21 2005-12-21 Nexmed Holdings, Inc. Prostaglandin compositions for the treatment of erectile dysfunction
EP3266458A1 (en) 2016-07-05 2018-01-10 Fagron B.V. Method and composition and kit for treating erectile dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
HUP0402673A2 (en) * 2002-02-15 2005-04-28 Nexmed (Holdings), Inc. Prostaglandin composition for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
CA2493723A1 (en) 2004-03-18
NO20050658L (en) 2005-04-01
JP2006512291A (en) 2006-04-13
EP1534297A1 (en) 2005-06-01
IL166273A0 (en) 2006-01-15
AU2003273291A1 (en) 2004-03-29
CN1674912A (en) 2005-09-28
KR20050057245A (en) 2005-06-16
WO2004022064A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
DE60335743D1 (en) COMPOUNDS AND METHOD FOR INCREASING THE NEUROGENESIS
EA200300527A1 (en) NEW TREATMENT METHODS FOR TIRED FOOT SYNDROME
EA200000563A1 (en) METHODS OF TREATMENT OF WOMEN IN POST-CLIMACTERISTIC CONDITION WITH THE USE OF ULTRANIZED ESTROGEN DOSES
ATE349446T1 (en) AMYLOID PLAQUE AGGREGATION INHIBITORS AND DIAGNOSTIC IMAGING AGENTS
EA200300717A1 (en) Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
BE2012C040I2 (en)
BR0116452A (en) Compound, pharmaceutical composition, use of a compound
EA200100688A1 (en) NITROGEN-CONTAINING HETEROBICYCLES AS INHIBITORS FACTOR Xa
DE69732868D1 (en) Remedy for itching
ATE507576T1 (en) ION EXTRACTION DEVICES AND METHOD FOR THE SELECTIVE EXTRACTION OF IONS
MX2007009032A (en) Formulations for injection of catecholic butanes, including ndga compounds, into animals.
EA200401345A1 (en) TREATMENT OF GASTROPAREZES
DE60041761D1 (en) TRIBONEKTINE
ATE466595T1 (en) COMPOUNDS AND METHODS FOR DOWNREGULATING THE EFFECTS OF TGF-BETA
ATE522230T1 (en) BIPHENYLE AS AN IMAGING AGENT IN ALZHEIMER'S DISEASE
EA200500452A1 (en) METHODS OF TREATING ERECTILE DYSFUNCTION IN MEN
PL377441A1 (en) Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers
EA200300125A1 (en) APPLICATION OF CABERGOLINE FOR THE TREATMENT OF POLYSYSTEMIC ATROPHY AND PROGRESSIVE SUPRANUKLEAR PARALICH
ATE460938T1 (en) MORPHOLINE DERIVATIVES FOR USE AS DOPAMINE AGONISTS IN THE TREATMENT OF, AMONG OTHERS. SEXUAL DYSFUNCTION
EA200200798A1 (en) CALCYLYTIC COMPOUNDS
EA200500878A1 (en) CALCYLYTIC COMPOUNDS
PT910398E (en) METHOD OF STIMULATION OF CILES
EA200300388A1 (en) 1-Aminoalkyl cyclohexanes as tripanocidal agents
ATE319839T1 (en) METHOD FOR IMPROVING TRANSFECTION EFFICIENCY